Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Human Capital & Careers
Salary Transparency’s Impact On the Future of Labor
With salary ranges being required in more areas, how can executives use these new laws to better their hiring practices?
By
Adam Zaki
| February 3, 2023
Read More
Resources
CFO Live
2022 Survey
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
2022 Survey
Sign Up
Sponsored by
Merck
People
CFOs On the Move: Week Ending March 26
Condé Nast, Foot Locker, Velocity, Merck, DNA Script, Ibotta, Cano Health, Ring Energy, PG&E, Adobe
By
Lauren Muskett
| March 26, 2021
Read More
People
CFOs On the Move: Week Ending February 5
Merck, Fetch Rewards, L Brands, Royal Cup Coffee & Tea, The Children’s Place, SMART Global Holdings, RealNetworks, Idea Financial, Virta Health
By
Lauren Muskett
| February 5, 2021
Read More
Risk & Compliance
Merck Drops Out of COVID-19 Vaccine Race
Merck's announcement that it is shelving its two vaccine candidates "marks a shocking setback for one of the most storied vaccine makers."
By
Matthew Heller
| January 25, 2021
Read More
M&A
Merck Buys OncoImmune in COVID Treatment Move
The $425 million deal gives Merck access to a promising therapy for treating seriously ill COVID-19 patients.
By
Matthew Heller
| November 23, 2020
Read More
M&A
Merck Enters Race to Develop COVID Vaccine
The world's largest vaccine maker is no longer on the COVID sidelines after acquiring an Austrian biotech and teaming up with a nonprofit.
By
Matthew Heller
| May 26, 2020
Read More
M&A
Merck, Sanofi in Deals for Cancer Drug Firms
The pharma giants each announced they would buy smaller drugmakers to expand cancer-treatment franchises.
By
Lauren Muskett
| December 9, 2019
Read More
M&A
Merck Goes Hostile in Versum Takeover Battle
Versum shareholders are scheduled to vote next month on a merger with Entegris that is valued at less than Merck's $5.9 billion proposal.
By
Matthew Heller
| March 27, 2019
Read More
M&A
Bayer to Shed Assets, Cut Jobs Amid Share Pressure
It's a broad restructuring of the German conglomerate, which plans to sell its sun-care and foot care businesses and exit its animal health division.
By
William Sprouse
| November 29, 2018
Read More
M&A
P&G Buys Merck Unit to Boost OTC Business
The $4 billion acquisition of Merck's consumer healthcare unit comes amid investor pressure on P&G to increase sales.
By
Matthew Heller
| April 19, 2018
Read More
Risk Management
Data Held Hostage
The damage inflicted in this year’s ransomware attacks will force corporations to review their IT resilience.
By
Vincent Ryan
| September 28, 2017
Read More
Technology
Quantifying Cyber Risks
Companies are clamoring for the data and information they need to manage their exposures.
By
David Katz
| December 15, 2016
Read More
Strategy
Merck Buys Cough Drug Developer for $1.25B
The acquisition of Afferent Pharmaceuticals gives Merck access to a drug candidate for treating neurogenic conditions including chronic cough.
By
Katie Kuehner-Hebert
| June 10, 2016
Read More
Risk & Compliance
Ex-Merck Analyst Hit with Insider Trading Rap
He allegedly helped a friend make more than $700,000 on insider M&A info.
By
Matthew Heller
| October 15, 2014
Read More
Staffing
CFOs on the Move: Week Ended March 28
Merck, AlixPartners, Laboratory Corp. of America, Catamaran, Bell and Howell, Cyan, RealPage, WPX Energy
By
Joan Urdang
| March 28, 2014
Read More
Technology
Transforming Cisco: One Finance Function At a Time
Cisco's shares have made a comeback, and CFO Frank Calderoni says a finance unit revamp was one of the key pieces of the company's turnaround.
By
Kathy Hoffelder
| October 10, 2013
Read More
Next